{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T04:08:33Z","timestamp":1776398913938,"version":"3.51.2"},"reference-count":28,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2010,2,1]],"date-time":"2010-02-01T00:00:00Z","timestamp":1264982400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2010,2]]},"DOI":"10.1016\/j.jns.2009.08.053","type":"journal-article","created":{"date-parts":[[2009,9,30]],"date-time":"2009-09-30T08:57:35Z","timestamp":1254301055000},"page":"115-118","source":"Crossref","is-referenced-by-count":45,"title":["Therapy adherence issues in Parkinson's disease"],"prefix":"10.1016","volume":"289","author":[{"given":"Donald","family":"Grosset","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.jns.2009.08.053_bib1","first-page":"2114","article-title":"Compliance to drug treatment of patients with rheumatoid arthritis: a 3 year longitudinal study","volume":"26","author":"Viller","year":"1999","journal-title":"J Rheumatol"},{"issue":"11","key":"10.1016\/j.jns.2009.08.053_bib2","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1111\/j.1528-1157.1995.tb00469.x","article-title":"Dose frequency and dose interval compliance with multiple antiepileptic medications during a controlled clinical trial","volume":"36","author":"Cramer","year":"1995","journal-title":"Epilepsia"},{"issue":"1","key":"10.1016\/j.jns.2009.08.053_bib3","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/S0738-3991(78)80033-0","article-title":"Patient compliance with antihypertensive regimens","volume":"1","author":"Sackett","year":"1978","journal-title":"Patient Couns Health Educ"},{"issue":"5","key":"10.1016\/j.jns.2009.08.053_bib4","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.2337\/diacare.27.5.1218","article-title":"A systematic review of adherence with medications for diabetes","volume":"27","author":"Cramer","year":"2004","journal-title":"Diabetes Care"},{"issue":"5","key":"10.1016\/j.jns.2009.08.053_bib5","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1002\/mds.20041","article-title":"Drug adherence in Parkinson's disease","volume":"19","author":"Leopold","year":"2004","journal-title":"Mov Disord"},{"issue":"11","key":"10.1016\/j.jns.2009.08.053_bib6","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1002\/mds.20602","article-title":"Suboptimal medication adherence in Parkinson's disease","volume":"20","author":"Grosset","year":"2005","journal-title":"Mov Disord"},{"issue":"3","key":"10.1016\/j.jns.2009.08.053_bib7","doi-asserted-by":"crossref","first-page":"202","DOI":"10.2165\/00003088-199427030-00004","article-title":"Role of patient compliance in clinical pharmacokinetics. A review of recent research","volume":"27","author":"Urquhart","year":"1994","journal-title":"Clin Pharmacokinet"},{"issue":"4","key":"10.1016\/j.jns.2009.08.053_bib8","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1093\/clinchem\/39.4.629","article-title":"Measuring L-dopa in plasma and urine to monitor therapy of elderly patients with Parkinson disease treated with L-dopa and a dopa decarboxylase inhibitor","volume":"39","author":"Dutton","year":"1993","journal-title":"Clin Chem"},{"issue":"2","key":"10.1016\/j.jns.2009.08.053_bib9","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1093\/ageing\/23.2.138","article-title":"Routine outpatient L-dopa monitoring in elderly patients with Parkinson's disease","volume":"23","author":"Copeland","year":"1994","journal-title":"Age Ageing"},{"issue":"6","key":"10.1016\/j.jns.2009.08.053_bib10","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/clpt.1990.211","article-title":"Improved compliance measures: applications in an ambulatory hypertensive drug trial","volume":"48","author":"Rudd","year":"1990","journal-title":"Clin Pharmacol Ther"},{"issue":"10","key":"10.1016\/j.jns.2009.08.053_bib11","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S1474-4422(03)00529-5","article-title":"Compulsive use of dopamine replacement therapy in Parkinson's disease: reward systems gone awry?","volume":"2","author":"Lawrence","year":"2003","journal-title":"Lancet Neurol"},{"issue":"1","key":"10.1016\/j.jns.2009.08.053_bib12","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1002\/mds.870130111","article-title":"Ropinirole in the treatment of early Parkinson's disease: a 6-month interim report of a 5-year levodopa-controlled study. 056 Study Group","volume":"13","author":"Rascol","year":"1998","journal-title":"Mov Disord"},{"issue":"2","key":"10.1016\/j.jns.2009.08.053_bib13","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1001\/jama.278.2.125","article-title":"Safety and efficacy of pramipexole in early Parkinson disease. A randomized dose-ranging study. Parkinson Study Group","volume":"278","year":"1997","journal-title":"JAMA"},{"issue":"12","key":"10.1016\/j.jns.2009.08.053_bib14","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.2165\/00019053-200119120-00001","article-title":"Accounting for noncompliance in pharmacoeconomic evaluations","volume":"19","author":"Hughes","year":"2001","journal-title":"Pharmacoeconomics"},{"issue":"21","key":"10.1016\/j.jns.2009.08.053_bib15","doi-asserted-by":"crossref","first-page":"2779","DOI":"10.1001\/jama.269.21.2779","article-title":"The rational clinical examination. Is this patient taking the treatment as prescribed?","volume":"269","author":"Stephenson","year":"1993","journal-title":"JAMA"},{"issue":"22","key":"10.1016\/j.jns.2009.08.053_bib16","doi-asserted-by":"crossref","first-page":"3273","DOI":"10.1001\/jama.261.22.3273","article-title":"How often is medication taken as prescribed? A novel assessment technique","volume":"261","author":"Cramer","year":"1989","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.jns.2009.08.053_bib17","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1164\/ajrccm\/146.6.1559","article-title":"Metered-dose inhaler adherence in a clinical trial","volume":"146","author":"Rand","year":"1992","journal-title":"Am Rev Respir Dis"},{"issue":"2","key":"10.1016\/j.jns.2009.08.053_bib18","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1136\/jnnp.2005.064709","article-title":"Measuring therapy adherence in Parkinson's disease: a comparison of methods","volume":"77","author":"Grosset","year":"2006","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"6","key":"10.1016\/j.jns.2009.08.053_bib19","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1002\/mds.22112","article-title":"Adherence to antiparkinson medication in a multi-centre European study","volume":"24","author":"Grosset","year":"2009","journal-title":"Mov Disord."},{"issue":"8","key":"10.1016\/j.jns.2009.08.053_bib20","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1016\/S0149-2918(01)80109-0","article-title":"A systematic review of the associations between dose regimens and medication compliance","volume":"23","author":"Claxton","year":"2001","journal-title":"Clin Ther"},{"issue":"21","key":"10.1016\/j.jns.2009.08.053_bib21","doi-asserted-by":"crossref","first-page":"3278","DOI":"10.1001\/archinte.160.21.3278","article-title":"Depression and diabetes: impact of depressive symptoms on adherence, function, and costs","volume":"160","author":"Ciechanowski","year":"2000","journal-title":"Arch Intern Med"},{"issue":"14","key":"10.1016\/j.jns.2009.08.053_bib22","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1001\/archinte.160.14.2101","article-title":"Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence","volume":"160","author":"DiMatteo","year":"2000","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jns.2009.08.053_bib23","article-title":"The parkinsonism\u2013hyperpyrexia syndrome","author":"Newman","year":"2008","journal-title":"Neurocrit Care"},{"issue":"5","key":"10.1016\/j.jns.2009.08.053_bib24","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1002\/ana.410250509","article-title":"Continuous and intermittent levodopa differentially affect basal ganglia function","volume":"25","author":"Juncos","year":"1989","journal-title":"Ann Neurol"},{"issue":"2","key":"10.1016\/j.jns.2009.08.053_bib25","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1002\/mds.870130207","article-title":"De novo administration of ropinirole and bromocriptine induces less dyskinesia than L-dopa in the MPTP-treated marmoset","volume":"13","author":"Pearce","year":"1998","journal-title":"Mov Disord"},{"issue":"1","key":"10.1016\/j.jns.2009.08.053_bib26","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/0014-2999(90)94802-5","article-title":"Effect of chronic treatment of MPTP monkeys with dopamine D-1 and\/or D-2 receptor agonists","volume":"178","author":"Gagnon","year":"1990","journal-title":"Eur J Pharmacol"},{"issue":"20","key":"10.1016\/j.jns.2009.08.053_bib27","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1056\/NEJM200005183422004","article-title":"A five-year study of the incidence of dyskinesia in patients with early Parkinson's disease who were treated with ropinirole or levodopa. 056 Study Group","volume":"342","author":"Rascol","year":"2000","journal-title":"N Engl J Med"},{"issue":"15","key":"10.1016\/j.jns.2009.08.053_bib28","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1001\/jama.284.15.1931","article-title":"Pramipexole vs levodopa as initial treatment for Parkinson disease: a randomized controlled trial","volume":"284","year":"2000","journal-title":"JAMA"}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X09008235?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X09008235?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,22]],"date-time":"2020-05-22T16:30:57Z","timestamp":1590165057000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X09008235"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,2]]},"references-count":28,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2010,2]]}},"alternative-id":["S0022510X09008235"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2009.08.053","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2010,2]]}}}